WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001003696) PHARMACEUTICAL AND NUTRITIONAL COMPOSITIONS CONTAINING ESSENTIAL FATTY ACIDS AND HOMOCYSTEINE-LOWERING AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/003696    International Application No.:    PCT/GB2000/002681
Publication Date: 18.01.2001 International Filing Date: 11.07.2000
Chapter 2 Demand Filed:    14.02.2001    
IPC:
A61K 31/70 (2006.01)
Applicants: LAXDALE LIMITED [GB/GB]; Kings Park House, Laurelhill Business Park, Polwaise Road, Stirling FK7 9JQ, Scotland (GB) (For All Designated States Except US).
HORROBIN, David, Frederick [GB/GB]; (GB) (For US Only).
GOUAILLE, Christina [SE/SE]; (SE) (For US Only)
Inventors: HORROBIN, David, Frederick; (GB).
GOUAILLE, Christina; (SE)
Agent: WAKERLEY, Helen, Rachael; Reddie & Grose, 16 Theobalds Road, London WC1X 8PL (GB)
Priority Data:
9916536.7 14.07.1999 GB
Title (EN) PHARMACEUTICAL AND NUTRITIONAL COMPOSITIONS CONTAINING ESSENTIAL FATTY ACIDS AND HOMOCYSTEINE-LOWERING AGENTS
(FR) COMPOSITIONS PHARMACEUTIQUES ET NUTRITIONNELLES RENFERMANT DES ACIDES GRAS ESSENTIELS ET DES AGENTS DE REDUCTION DE L'HOMOCYSTEINE
Abstract: front page image
(EN)The combined application of at least one essential fatty acid of the n-6 or n-3 series, optionally together with further essential fatty acid(s) of the n-6 or n-3 series, together with one or more homocysteine lowering agent. The homocysteine lowering agent is selected from vitamin B12, folic acid, a compound related to folic acid with similar biological activity and vitamin B6.
(FR)L'invention concerne l'application associée d'au moins un acide gras essentiel de la série n-6 ou n-3, éventuellement associé à un ou à plusieurs acides gras supplémentaires de la série n-6 ou n-3, et associé à un ou à plusieurs agents de réduction de l'homocystéine. L'agent de réduction de l'homocystèine est sélectionné parmi la vitamine B12, l'acide folique, un composé apparenté à l'acide folique présentant une activité biologique semblable, et la vitamine B6.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)